CME

This conference is designed for interventional cardiologists, cardiac and vascular surgeons, nurse practitioners and physician assistants, interventional radiologists and other healthcare professionals interested in the optimal practice of interventional, structural, peripheral, and preventive cardiovascular medicine.

Cardiovascular practice has never evolved more rapidly than today as cardiologists and surgeons collaborate to offer exciting new options for percutaneous and minimally invasive hybrid therapies. Arteries, valves, veins, infracting, hypertrophied myocardium and other anatomic sites are targets for intervention and symptom relief in a vast array of cardiovascular pathology including STEMI, unstable angina/non-STEMI, cardiogenic shock, aortic stenosis, mitral regurgitation, acute stroke, claudication and limb salvage, chronic valvular and perivalvular defects and many other conditions including adult congenital heart disease. This course will feature the cumulative wisdom of 20 academic centers with live case demonstrations, lectures, presentations and discussions of complex cases, debates between well-known interventionalists and surgeons and the opportunity for insightful audience participation and discussion. The national concern regarding appropriate selection for diagnostic studies and intervention will be addressed in detail. The conference will feature joint sessions as well as dedicated tracks for coronary, structural/peripheral, and preventive intervention.

LEARNING OBJECTIVES

Learning Objectives
Upon completion of this activity, participants will be able to:
» Recognize the efficiency of novel techniques and review current state-of-the-art approaches to
the optimal practice of coronary, structural, and peripheral interventions.
» Explain the improvement in clinical outcomes following optimal percutaneous and surgical
management of complex coronary artery disease, including chronic total inclusions, cardiogenic
shock, and cardiac arrest.
» Discuss the next generation drug-eluting stents and drug-eluting balloons, and how they can
prevent the leading causes of stent failure, which are stent thrombosis, stent restenosis, and
neoatherosclerosis.
» Review safety and efficacy of transcatheter aortic, mitral, and tricuspid valve replacements and
repairs in high- and intermediate-risk patients.
» Evaluate the prevalence of microvascular and vasospastic disease and describe their novel
pharmacologic interventions to treat the conditions.
» Appraise the safety and efficacy of ventricular assist devices in heart failure.
» Summarize novel catheter-based treatments of cardiac arrhythmias.
» Explain the indications for invasive physiologic (FFR, iFR) and imaging assessment (IVUS, OCT) of
lesion severity to determine optimal revascularization strategies.
» Review developments in therapies for thromboembolism prevention including pharmacotherapy
and left atrial appendage occlusion devices
» Describe the mechanisms of action and clinical applicability of lipid-lowering agents for primary
or secondary prevention of coronary artery disease.

ACCREDITATION & CREDIT DESIGNATION

Instructions To Receive CME Credit for EPIC-SEC 2020
To receive credit, participants are required to complete an evaluation. After the meeting visit the
ACHL Website using the instructions below. These instructions will also be emailed to you and posted
on the EPIC-SEC Website.
1. Go to www.ACHLcme.org
2. Click on “Use Certificate Code”
3. Enter the Certificate Code 4227826
4. Login or register
5. Complete the evaluation and your certificate will be immediately available to you.
We request that you verify the total hours of education received, based on CME-certified sessions
attended. We encourage you to track your attendance to help facilitate this process.
For questions, please contact Melissa Stradal at mstradal@achlcme.org.

TARGET AUDIENCE
ACTIVITY PURPOSE
Spencer King Banner.png
  • Facebook App Icon
  • Twitter App Icon

Copyright © 2018  |    EPIC-SEC  |   All Rights Reserved.